Global Expansion Codis has recently increased its headcount and expanded its UK operations, signaling a strategic push into international markets and creating new sales opportunities in regions requiring advanced particle engineering and pharmaceutical manufacturing services.

Product Innovation With capabilities in spray drying, amorphous solid dispersions, and particle engineering, Codis offers differentiated solutions that can appeal to pharmaceutical companies seeking high-performance formulations, presenting potential collaboration or contract manufacturing opportunities.

Market Positioning As a newly merged entity with a substantial revenue range between $50M and $100M, Codis is positioning itself as a competitive CDMO, opening avenues to partner with mid-sized and large pharmaceutical companies looking for reliable manufacturing partners.

Leadership Growth The recent appointment of a Senior VP of Sales & Marketing and job growth indicate a focus on expanding customer engagement and market reach, creating opportunities for sales teams to establish relationships with key decision-makers within the company.

Technical Capabilities Codis’s expertise in particle engineering and advanced spray drying technology positions it as a strategic partner for pharmaceutical firms developing complex or innovative drug delivery systems, providing opportunities for technical sales and collaborative development projects.